CENCI, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 240
EU - Europa 171
AS - Asia 110
SA - Sud America 1
Totale 522
Nazione #
US - Stati Uniti d'America 239
SE - Svezia 66
SG - Singapore 59
RU - Federazione Russa 48
CN - Cina 43
IT - Italia 23
FI - Finlandia 15
DE - Germania 13
AE - Emirati Arabi Uniti 5
IE - Irlanda 2
IN - India 2
NL - Olanda 2
UA - Ucraina 2
BR - Brasile 1
CA - Canada 1
HK - Hong Kong 1
Totale 522
Città #
Singapore 36
Shanghai 32
Ashburn 31
Boardman 26
Lawrence 26
Princeton 26
New York 18
Moscow 14
Helsinki 13
Milan 12
Los Angeles 6
Seattle 6
Dubai 5
Washington 5
Verona 3
Dublin 2
Landshut 2
Lappeenranta 2
Mykolayiv 2
Presezzo 2
Pune 2
Santa Clara 2
Bologna 1
Chapel Hill 1
Hong Kong 1
Issogne 1
Naaldwijk 1
Rome 1
Saint Martinville 1
San Diego 1
San Francisco 1
Sezze 1
Toronto 1
Totale 284
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 22
Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by ¹H HR-MAS NMR Metabolomics. 21
Autophagy mediates epithelial cancer chemoresistance by reducing p62/SQSTM1 accumulation 20
The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis 18
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 18
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 17
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 17
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 16
Dampening Ab responses using proteasome inhibitors following in vivo B cell activation 16
Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors 16
A New Fluorogenic Peptide Determines Proteasome Activity in Single Cells 16
ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE 15
Iron increases the susceptibility of multiple myeloma cells to bortezomib 15
Autophagy in Plasma Cells 14
Autophagy, a new determinant of plasma cell differentiation and antibody responses 14
Managing and exploiting stress in the antibody factory 14
Editorial: Advances in Plasma Cells in Health and Disease 13
Ex vivo gene expression of osteoblasts in maxillary sinus grafting 13
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity 13
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 13
MHC Class II Transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity 13
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 12
Autophagy in Plasma Cell Ontogeny and Malignancy 12
Autophagy and longevity: Evolutionary hints from hyper-longevous mammals 12
FAM46C-dependent tuning of endoplasmic reticulum capacity in Multiple Myeloma 12
CHOP-independent apoptosis and pathway-selective induction of the UPR in developing plasma cells 12
Plasma cells require autophagy for sustainable immunoglobulin production 12
Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells 11
Metabolomics of B to Plasma Cell Differentiation 11
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator 10
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition 10
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel 9
B lymphocytes inhibit human osteoclastogenesis by secretion of TGF beta 9
Autophagy in plasma cell pathophysiology 9
Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo 9
Proteostenosis and Plasma Cell Pathophysiology 9
Proteotoxic stress and cell lifespan control 8
PROGRESSIVELY IMPAIRED PROTEASOMAL CAPACITY DURING TERMINAL PLASMA CELL DIFFERENTIATION 8
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator 8
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling 8
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 7
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma 7
Toll-like receptor 9 stimulation can induce I kappa B zeta expression and IgM secretion in chronic lymphocytic leukemia cells 7
Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease 6
Autophagy in the regulation of protein secretion in immune cells 6
Therapeutic Efficacy of Hematopoietic Stem Cell Gene Therapy for Hurler Type 1 Mucopolysaccharidosis 6
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis 5
The problem of arteriovenous malformations of the spinal cord in the elderly: Case report of an octogenarian 5
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes 5
A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver 5
PROTEOSTASIS AS A SIGNALING DEVICE AND THERAPEUTIC TARGET 5
The role of autophagy in plasma cell ontogenesis 4
Hip fracture in nursing homes: An Italian study on prevalence latency, risk factors, and impact on mobility 4
Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency 4
Short-term reproducibility of proximal femur bone mineral density in the elderly 4
M-CSF neutralization and Egr-1 deficiency prevent ovariectomy-induced bone loss 3
Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines 3
Recent advances and future directions in targeting the secretory apparatus in multiple myeloma 3
T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappa B ligand-dependent and -independent mechanisms 2
null 1
null 1
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma 1
The Proteasome in Terminal Plasma Cell Differentiation 1
Totale 620
Categoria #
all - tutte 8.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 3 0 0 0 0 1 0 0 0 0 0 0
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2021/202218 0 0 2 6 1 3 3 0 3 0 0 0
2022/2023153 58 30 6 0 1 15 3 5 6 18 10 1
2023/2024344 38 31 62 30 19 37 9 37 0 8 13 60
2024/202586 86 0 0 0 0 0 0 0 0 0 0 0
Totale 620